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Introduction
Macrophage activation syndrome (MAS) is a potentially
fatal complication of childhood rheumatic diseases (RD),
due to excessive activation and proliferation of macro-
phages. It belongs to secondary forms of Hemophagocy-
tic lymphohistiocytosis (HLH), including HLH-infection
associated forms (HLH-IA).
Objectives
The aim of our study is to assess the prevalence of clini-
cal and laboratory features, possible triggers and out-
comes of MAS.
Methods
We retrospectively evaluated a cohort of 12 patients with
MAS and HLH-IA, observed at the U.O.S. Pediatric
Rheumatology, from 2005 to 2014. Here we report: sex,
ethnicity, RD, age at the onset of the rheumatic disease,
age at the onset of MAS, duration of the disease pre-
MAS; clinical and laboratory features; results of the bone
marrow biopsy if performed; trigger factors, treatments
and outcomes.
Results
We identified 12 patients: 9 MAS and 3 HLH-IA;
9 females and 3 males; 10 Caucasians, 1 Egyptian and 1
Latin American. The mean age at diagnosis of MAS was
9.25 years. 9 children had RD: 6 systemic juvenile idio-
pathic arthritis, 1 dermatomyositis, 1 autoinflammatory
disease and 1 systemic lupus erythematosus. In 3 cases
MAS occurred during the first presentation of the RD. In
all cases, RD status was active during MAS. The mean
age at onset of RD was 7.8 years. HLA-IA and MAS
could occur at the onset of the RD with an interval of
22 days or later in the course of RD with an interval of
1105 days on average. Organ involvement was: hepato-
megaly 12, splenomegaly 7, lymphoadenopathy 5, bleed-
ing 2, central nervous system 6, heart 8, lung 4, kidney 5
and gallbladder 2.
Table 1 summarizes patients’ characteristics, the clini-
cal and laboratory features and number of cases.
In 11 cases the possible trigger was an infectious epi-
sode. We identified 5 bacterial infections (Chlamydia
pneumoniae, Mycoplasma pneumoniae, Clostridium dif-
ficilis, group A beta-hemolytic Streptococcus, Staphylo-
coccus aureus), 2 viral infections Chickenpox virus,
Epstein-Barr virus and one multiple protozoal infection
(Entamoeba histolytica, Endolimax nana). In 4 cases
there were signs suggestive of infection, including lower
respiratory tract infection, skin infection, urinary tract
infection, gastroenteritis, but it was not possible to iden-
tify a pathogen.
UOS Reumatologia Pediatrica, Fondazione IRCCS Ca’ Granda, Ospedale
Maggiore Policlinico, Milano, Italy
Table 1
Persistent fever ≥38°C 12 Decreased platelet count 12
Hyperferritinemia (≥1000 ng/ml) 12 Decreased erythrocyte sedimentation rate 12
Increased liver enzyme levels 11 Decreased leukocyte count 11
Hypofibrinogenemia 10 Hypertriglyceridemia 9
Hemophagocytosis in bone marrow biopsy 6/8
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All patients were treated with methylprednisolone and
cyclosporine. 9 received transfusions of fresh frozen
plasma, 7 blood transfusions and 4 intravenous immuno-
globulins. Regarding the outcomes, 1 patient died. 3 had
sequelae: seizures in 1, 1 spastic quadriplegia and 1 flaccid
paralysis of half body, with a motor type polyneuropathy.
Conclusion
In our cases, RD was in active phase at the time of diag-
nosis of MAS, regardless of the time elapsed since the
first diagnosis. The infection appears to have a triggering
role in the MAS, including Entamoeba hystolitica and
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